Detalles de la búsqueda
1.
Vimentin expression correlates with immune checkpoint inhibitor efficacy in non-small cell lung cancer.
Cancer
; 129(15): 2297-2307, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021822
2.
Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin plus Etoposide Therapy.
Oncology
; 2023 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160673
3.
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non-small cell lung cancer.
Cancer Sci
; 113(9): 3148-3160, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722982
4.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
Int J Clin Oncol
; 27(4): 695-706, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35182247
5.
Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non-small cell lung cancer patients with asymptomatic brain metastases.
Invest New Drugs
; 39(6): 1598-1603, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215931
6.
CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.
Int J Clin Oncol
; 26(9): 1628-1639, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117553
7.
Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Cancer Sci
; 111(5): 1724-1738, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32159882
8.
Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.
Invest New Drugs
; 38(6): 1901-1905, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32399862
9.
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer.
Cancer Sci
; 110(10): 3244-3254, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31368625
10.
Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancer.
Invest New Drugs
; 36(2): 350-353, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29018997
11.
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(5): 663-671, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28343976
12.
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.
Cancer Sci
; 107(11): 1667-1676, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581340
13.
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors.
Invest New Drugs
; 34(3): 347-54, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27000274
14.
Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report.
Anticancer Drugs
; 27(3): 251-3, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26575001
15.
Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma.
Dig Dis
; 34(6): 702-707, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27750241
16.
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 16(16): 1630-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522337
17.
Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.
Invest New Drugs
; 33(2): 380-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502863
18.
Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study.
Clin Lung Cancer
; 25(2): 144-150.e3, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042690
19.
Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.
Cancer
; 119(12): 2275-81, 2013 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23558513
20.
Bronchoscopic findings for bevacizumab-related pulmonary hemorrhage in advanced non-small cell lung cancer.
Invest New Drugs
; 31(5): 1364-6, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23525757